{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-021031","form_type":"8-K","ticker":"GNPX","cik":"0001595248","company_name":"Genprex, Inc.","filed_at":"2024-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.140657+00:00","generated_at":"2026-06-01T02:28:02.829714+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Genprex CEO Confer Gets Salary Hike, Title Upgrade; Former EVP Vaczy Receives $350K Severance","bullets":["Ryan Confer confirmed as President, CEO and CFO; base salary increased to $480,000 per year; severance reference period extended from 12 to 18 months.","Separating EVP Catherine Vaczy receives $300,000 plus $50,000 severance, acceleration of 6,125 RSUs and 4,374 options.","At June 18 annual meeting, director Brent Longnecker elected; ratification of WithumSmith+Brown as auditor; advisory say-on-pay approved and frequency set to every year.","Board adopted amended Outside Director Compensation Policy adding $15,000 annual cash retainer for non-executive Chairman."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-021031","json":"https://secwatch.observer/filing/0001437749-24-021031.json","markdown":"https://secwatch.observer/filing/0001437749-24-021031.md","text":"https://secwatch.observer/filing/0001437749-24-021031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595248/000143774924021031/0001437749-24-021031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595248/000143774924021031/gnpx20240503_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:28:02.829714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b700322093","claim":"Ryan M. Confer changed role as President, Chief Executive Officer and Chief Financial Officer at Genprex, Inc..","evidence_excerpt":"Mr. Confer’s title change to President, Chief Executive Officer and Chief Financial Officer was confirmed","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774924021031/0001437749-24-021031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"confirmed"},{"label":"Role","value":"President, Chief Executive Officer and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"ea10816bfd","claim":"Catherine Vaczy resigned as Executive Vice President, General Counsel and Chief Strategy Officer at Genprex, Inc..","evidence_excerpt":"Catherine Vaczy, the Company’s then Executive Vice President, General Counsel and Chief Strategy Officer, notified the Company of her intention to resign.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774924021031/0001437749-24-021031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Vice President, General Counsel and Chief Strategy Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}